Varicella vaccine given subcutaneously (under the skin). It is recommended for all children under 13 and for everyone 13 or older who has never had chickenpox. In the United States two doses are recommended. In the first case a first dose is administered at 12 to 15 months and a second dose at age 4–6 years. For people older than 13 the two doses are administered 4 to 8 weeks apart. The varicella vaccine did not become widely available in the United States until 1995. In the UK, the vaccine is only recommended in people who are particularly vulnerable to chickenpox. The
International Society for Disease Surveillance biosurveillance. Every year, the ISDS conference draws over 350 professionals from a broad range of disciplines to learn the latest achievements, analytic methods, best practices, conceptual frameworks, and technical innovations in the rapidly evolving field of disease surveillance. The ISDS conferences provide fertile ground for cultivating new ideas and partnerships by bringing together local, state, and federal public health practitioners, academic researchers, clinicians, policymakers, and decision makers from governmental and nongovernmental entities. The 12th annual conference was held in December 2013, in New Orleans, LA. The theme for the 2013 conference—Translating Research and Surveillance into Action—highlighted one of the salient